BMJ Open Diabetes Research & Care (Apr 2020)

tRNA methyltransferase 10 homologue A (TRMT10A) mutation in a Chinese patient with diabetes, insulin resistance, intellectual deficiency and microcephaly

  • Xuefeng Chen,
  • Ke Huang,
  • Guan-Ping Dong,
  • Hu Lin,
  • Xuelian Zhou,
  • Yangxi Li

DOI
https://doi.org/10.1136/bmjdrc-2020-001601
Journal volume & issue
Vol. 8, no. 1

Abstract

Read online

Introduction Loss-of-function mutations in tRNA methyltransferase 10 homologue A (TRMT10A), a tRNA methyltransferase, have recently been described as a monogenic cause of early-onset diabetes with microcephaly, epilepsy and intellectual disability.Research design and methods We report a Chinese young patient who was diagnosed with diabetes mellitus as a result of a TRMT10A mutation.Results A homozygous mutation c.496–1G>A in TRMT10A was identified using targeted next-generation sequencing and confirmed by PCR/Sanger sequencing. In addition to being diagnosed with diabetes, the patient also has microcephaly and intellectual deficiency. The diabetes was due to marked insulin resistance and responded very well to metformin treatment.Conclusion Our case is the first report in the Asian population. It adds to current knowledge of TRMT10A related with young-onset non-insulin-dependent diabetes and confirms the a single previous report of insulin resistance in this syndrome. Genomic testing should be considered in children with non-insulin-dependent diabetes with intellectual disability and microcephaly. A clear genetic diagnosis is helpful for early detection and treatment addressing insulin resistance.